Download full-text PDF

Source
http://dx.doi.org/10.1016/0002-9378(51)91167-2DOI Listing

Publication Analysis

Top Keywords

urinary histidine
4
histidine massive
4
massive doses
4
doses progesterone
4
progesterone patients
4
patients carcinoma
4
carcinoma cervix
4
urinary
1
massive
1
doses
1

Similar Publications

Background/objectives: Thus far, no studies have examined the relationship between fruit and vegetable (F and V) intake, urinary metabolite quantities, and weight change. Therefore, the aim of the current study was to explore changes in urinary metabolomic profiles during and after a 10-week weight loss intervention where participants were prescribed a high F and V diet (7 servings daily).

Methods: Adults with overweight and obesity ( = 34) received medical nutrition therapy counselling to increase their F and V intakes to national targets (7 servings a day).

View Article and Find Full Text PDF

The objective of this experiment was to estimate the bioavailability (BA) of rumen-protected (RP) His, RPLys, and 2 RPMet products using 3 in vivo methods: area under the curve (AUC), plasma dose-response (PDR), and fecal free AA (FFAA) methods. We used 8 rumen-cannulated cows in a replicated 4 × 4 Latin square experiment with 16-d periods. Treatments were (1) abomasal infusion of water (control), (2) abomasal infusion of free His, Lys, and Met (FAA), (3) administration of RPHis + RPLys + RPMet1 (rumen-protected methionine protected with ethyl cellulose; RPAA1), and (4) administration of RPHis + RPLys + RPMet2 (rumen-protected methionine protected with a pH-sensitive polymer; RPAA2).

View Article and Find Full Text PDF

This study aimed to develop a compensatory growth model using growing beef cattle by changing dietary protein and to investigate the underlying mechanisms of compensatory protein deposition in muscle tissue. Twelve Charolais bulls were randomly assigned to one of two groups with two periods: 1) a control group (CON) fed a 13% crude protein (CP) diet for 6 weeks; 2) a treatment group (REC) fed a 7% CP diet for 4 weeks (restriction period) and fed a 13% CP diet in the following 2 weeks (re-alimentation period). Growth performance, digestibility, nitrogen balance, targeted metabolomics of amino acids (AA) in plasma, and transcriptional profiling in muscle tissue were analyzed.

View Article and Find Full Text PDF

Introduction: Urine metabolomics offers a non-invasive approach to diagnose and manage inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), by identifying distinct metabolic signatures.

Objectives: This narrative review summarizes current findings on urinary metabolites in IBD, evaluating their roles in disease differentiation, assessment of activity, and monitoring therapeutic response.

Methods: A comprehensive literature search of PubMed and MEDLINE up to October 2023 was conducted using keywords, such as 'urine metabolomics', 'inflammatory bowel disease', 'Crohn's disease', 'ulcerative colitis', and 'urinary biomarkers'.

View Article and Find Full Text PDF
Article Synopsis
  • - Chlorphenesin carbamate, a muscle relaxant, can metabolize into 4-chlorophenoxyacetic acid (4-CPA), which is banned by WADA, necessitating better identification methods in doping tests.
  • - A study analyzed urine samples from ten volunteers who ingested chlorphenesin carbamate, identifying a total of 29 metabolites through advanced mass spectrometry techniques.
  • - The findings indicate that two metabolites, M9 and M10, have longer detection windows, and the metabolic changes primarily involve histidine and β-alanine pathways, aiding in improving future doping control protocols.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!